Up next

Autoplay

Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD

6 Views • 07/30/23
Share
Embed
administrator
administrator
Subscribers
0

Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay